Navigation Links
Men with prostate cancer avoid radiation due to misconceptions

Negative perceptions about radiation therapy can strongly influence a prostate cancer patient's choice to avoid external beam radiation therapy, even though studies have proven the treatment to be as safe and effective as other treatments for the disease, including surgery, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.

"The study shows that patients base their treatment choice not only on technical information, but also on cultural and personal prejudices," said Riccardo Valdagni, M.D., an author of the study and head of the Prostate Programme at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. "It's important for patients to express their fears about radiation treatment to their doctors and for doctors to consider these worries and address any misconceptions about this therapy so that patients can make the best, most informed decision about their treatment."

Men with prostate cancer often choose between external beam radiation therapy, radiation seed implants and surgery to treat their cancer. During external beam radiation, a beam of radiation, or X-ray, is directed through the skin to the cancer and the immediate surrounding area to kill the cancer. To minimize side effects, radiation is given five days a week for several weeks. Many men with prostate cancer choose external beam radiation over other treatments because it is non-invasive, has a short recovery period and often helps men preserve their sexual and urinary function.

However, Dr. Valdagni's study shows that some men with prostate cancer have definite fears about radiation treatment, with the greatest worries related to false beliefs on how the X-rays would affect them. For example, some patients think that radiation cannot be controlled because it is invisible, that it will harm surrounding unprotected organs and that it is dangerous for family members t o physically be near them when undergoing radiation treatment. Patients also said that the terminology used in radiation therapy, such as the term "hitting the target," evoked feelings more related to war than to a cure. In addition, while some patients experienced technology as reassuring, many others felt that the technologically advanced computer equipment used during radiation treatment provoked anxiety.

The study was carried out by a multidisciplinary team of doctors (urologists, radiation oncologists, medical oncologists and psychologists) at the Milan National Cancer Institute Prostate Cancer Program from March 2005 to March 2006. The team interviewed 257 men with prostate cancer to find out their perceptions about radiation therapy.
'"/>

Source:American Society for Therapeutic Radiology and Oncology


Related biology news :

1. Mitochondrial DNA mutations play significant role in prostate cancer
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. Test for early detection of prostate cancer shows promise
4. U-M researchers identify new blood test for prostate cancer
5. U-M scientists say fused genes trigger the development of prostate cancer
6. Virus chip detects new virus in prostate tumors
7. Human prostate grown from embryonic stem cells
8. Curry and cauliflower could halt prostate cancer
9. Macrophage signaling may affect hormone resistance in prostate tumors
10. Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers
11. Vegetables inhibit growth of prostate cancer in mice with human tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: